How much does the Royalty Pharma CEO make?

Pablo Legorreta received $937,500 in total compensation for FY2025 as Chief Executive Officer of Royalty Pharma plc (RPRX), per Royalty Pharma plc's DEF 14A filed 10 Apr 2026 (accession 0001140361-26-014239).

Royalty Pharma ceo salary

Pablo Legorreta, Chief Executive Officer of Royalty Pharma plc (RPRX), received $937,500 ($938K) in total compensation for FY2025. Base salary of $937,500 was the largest component. Figures come from Royalty Pharma plc's DEF 14A filed 10 Apr 2026 (accession 0001140361-26-014239).

Reported total from the latest DEF 14A pay table. Source filing (accession 0001140361-26-014239). These figures come from Royalty Pharma plc's DEF 14A filed 10 Apr 2026 (accession 0001140361-26-014239).

Component	Amount
Salary	$937,500
Total	$937,500

FAQ

Common questions

How much does the Royalty Pharma CEO make?: Pablo Legorreta received $937,500 in total compensation for FY2025 as Chief Executive Officer of Royalty Pharma plc (RPRX), per Royalty Pharma plc's DEF 14A filed 10 Apr 2026 (accession 0001140361-26-014239).
Where does this number come from?: The numbers come from Royalty Pharma plc's DEF 14A filed 10 Apr 2026 (accession 0001140361-26-014239).